Authors


Adam Borden, MHA

Latest:

The Diagnosis for Diagnostics: Changes to Medicare Payment and Coverage of Clinical Laboratory Tests

The basis for determining Medicare payment rates for clinical diagnostic laboratory tests is changing. These changes will be important for all payers and providers to follow for future reimbursement and contract negotiations.


Thomas R. Graf, MD

Latest:

Moving Pharma Contracting Into the Era of Accountability

A chief medical officer for a major payer outlines the challenges making sure that certain high-cost therapies are directed to the patients who need them.










Jennifer Meddings, MD, MSc

Latest:

Small Practice Participation and Performance in Medicare Accountable Care Organizations

Medicare beneficiaries attributed to small practices in accountable care organizations (ACOs) achieve greater savings than beneficiaries attributed to large practices in ACOs.





Anna D. Coutinho, PhD, BPharm

Latest:

COPD Exacerbation Costs in the IMPACT Study: A Within-Trial Analysis

Treatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic obstructive pulmonary disease (COPD) in the US healthcare system.





William B. Greenough, III, MD

Latest:

Substitutive Hospital at Home for Older Persons: Effects on Costs

Substitutive Hospital at Home care for 4 common conditions is associated with cost savings.


Alyson Barrier, BBA

Latest:

Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer

Stereotactic body radiation therapy for low- to intermediate-risk prostate cancer has potential cost savings and may improve access to radiation, increase convenience, and boost quality of life.



Abir O. Kanaan, PharmD

Latest:

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.



Darline K. El Reda, DrPH, MPH

Latest:

Dialing In: Effect of Telephonic Wellness Coaching on Weight Loss

Small weight loss was reported by overweight/obese individuals targeted for telephonic wellness coaching in this large retrospective study using pre-post design.


Mark S. Roberts, MD, MPP

Latest:

Cost-Effectiveness of Pneumococcal Polysaccharide Vaccine Among Healthcare Workers During an Influenza Pandemic

Pneumococcal polysaccharide vaccination of healthcare workers during an influenza pandemic is cost-effective from a societal perspective but not from a hospital perspective without external subsidy.



Carolina M. Reyes, PhD

Latest:

Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis

Out-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices.




Amanda S. Parsons, MD

Latest:

Medicare Underpayment for Diabetes Prevention Program: Implications for DPP Suppliers

The actual costs of implementing the evidence-based Diabetes Prevention Program (DPP) were compared with the latest reimbursement rates provided by CMS.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo